Explore how we turn our research into reality.
About clinical trials
A critical component of developing medicines is clinical research. This involves conducting clinical trials in humans to evaluate the safety and efficacy of investigational medications. Sometimes these studies include healthy volunteers but most of the studies are conducted in patients living with the diseases we are studying.
There are important health benefits in making clinical trial data and information available to health care providers, researchers, patients and the general public. We are committed to sharing information regarding our clinical trials while respecting patient confidentiality and the rights of our scientists.
We register all clinical trials on the publicly available ClinicalTrials.gov and EU Clinical Trial registries. Regardless of outcomes, we disclose the results of our clinical trials on these registries. Results from clinical trials are also often published in peer-reviewed scientific or medical journal and presented at professional scientific or medical meetings.
We recognise the benefits of sharing our clinical trial information with researchers. That’s why qualified researchers engaged in rigorous, independent scientific research can request access to our anonymised clinical trial data.
Learn more about AbbVie clinical trials
Committed to Good Clinical Practice
Throughout the clinical trials process, patients remain our highest priority. Good Clinical Practice (GCP) is a global ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with global ethical standards and regulatory requirements. Compliance also assures the credibility of the clinical data. AbbVie is committed to ensuring Good Clinical Practice is strictly adhered to within all AbbVie-sponsored clinical trials.
Join our clinical trial site network
AbbVie partners with leading scientific and medical professionals around the world and in Ireland to conduct clinical trials. We value the significant contributions that our scientific and medical professional partners make to our scientific innovation. AbbVie is committed to establishing collaborative partnerships to continuously grow our clinical trial site network.
Investigator-Initiated Studies (IIS)
We’re committed to supporting investigator-initiated research that promotes the advancement of medical and scientific knowledge involving AbbVie’s products and therapeutic areas of interest.
Our Investigator-Initiated Studies (IIS) Programme, is open to academic and community based healthcare professionals and researchers globally to apply for research support.
If you’re an investigator, you can learn more about our research areas of interest and application process by visiting our global website.
IE-ABBV-260022
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.